Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Peppermint Helps Relieve Irritable Bowel Syndrome

By HospiMedica International staff writers
Posted on 26 Apr 2011
A new study describes how peppermint helps to relieve irritable bowel syndrome (IBS), which affects up to 20% of the population.

Researchers at the University of Adelaide (Australia) conducted a study to find out how peppermint (icilin) activates transient receptor potential ion channel melastatin subtype 8 (TRPM8) in colonic sensory pathways, since the underlying mechanisms of action are unclear. More...
Laser capture microdissection, quantitative reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence, and retrograde tracing were used to localize TRPM8 to colonic primary afferent neurons. In vitro extracellular single-fiber afferent recordings were used to determine the effect of TRPM8 channel activation on the chemosensory and mechanosensory function of colonic high-threshold afferent fibers.

The researchers found that a subpopulation of splanchnic serosal and mesenteric afferents tested responded directly to icilin. Icilin also prevented mechanosensory desensitization and sensitization induced by capsaicin--the active component of chilli peppers--and the transient receptor potential (TRP)A1 agonist AITC, respectively. The researchers found that TRPM8 was localized to high-threshold visceral afferent neurons, and that it couples to TRPA1 to inhibit downstream chemosensory and mechanosensory actions. On visceral afferent peripheral endings, TRPM8 activation affected TRPV1 and TRPA1 downstream chemosensory and mechanosensory actions. The study was published ahead of print on April 11, 2011, in Pain.

"Our research shows that peppermint acts through a specific antipain channel called TRPM8 to reduce pain sensing fibers, particularly those activated by mustard and chilli. This is potentially the first step in determining a new type of mainstream clinical treatment for Irritable Bowel Syndrome (IBS),” said lead author Stuart Brierley, PhD, of the Nerve-Gut Research Laboratory. "Some people find their symptoms appear after consuming fatty and spicy foods, coffee and alcohol, but it is more complex than that. There appears to be a definite link between IBS and a former bout of gastroenteritis, which leaves nerve pain fibers in a heightened state, altering mechanisms in the gut wall and resulting in ongoing pain.”

IBS (spastic colon) is a diagnosis of exclusion. It is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any detectable organic cause. In some cases, the symptoms are relieved by bowel movements. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C or IBS-A, respectively). IBS may begin after an infection (postinfectious, IBS-PI), a stressful life event, or onset of maturity without any other medical indicators.

Related Links:

University of Adelaide




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.